KCNJ2 Variant of Unknown Significance Reclassified as Long QT Syndrome Causing Ventricular Fibrillation

2011 ◽  
Vol 27 (6) ◽  
pp. 870.e11-870.e13 ◽  
Author(s):  
Manoj N. Obeyesekere ◽  
George J. Klein ◽  
Susan Conacher ◽  
Andrew D. Krahn

2020 ◽  
Vol 13 (6) ◽  
Author(s):  
Elizabeth A. Streeten ◽  
Vincent Y. See ◽  
Linda B.J. Jeng ◽  
Kristin A. Maloney ◽  
Megan Lynch ◽  
...  

Background: In population-based research exome sequencing, the path from variant discovery to return of results is not well established. Variants discovered by research exome sequencing have the potential to improve population health. Methods: Population-based exome sequencing and agnostic ExWAS were performed 5521 Amish individuals. Additional phenotyping and in vitro studies enabled reclassification of a KCNQ1 variant from variant of unknown significance to pathogenic. Results were returned to participants in a community setting. Results: A missense variant was identified in KCNQ1 (c.671C>T, p.T224M), a gene associated with long QT syndrome type 1, which can cause syncope and sudden cardiac death. The p.T224M variant, present in 1/45 Amish individuals is rare in the general population (1/248 566 in gnomAD) and was highly associated with QTc on electro-cardiogram ( P =5.53E-24, β=20.2 ms/allele). Because of the potential importance of this variant to the health of the population, additional phenotyping was performed in 88 p.T224M carriers and 54 noncarriers. There was stronger clinical evidence of long QT syndrome in carriers (38.6% versus 5.5%, P =0.0006), greater history of syncope (32% versus 17%, P =0.020), and higher rate of sudden cardiac death in first degree relatives<age 30 (4.5% versus 0%, P =0.026). Expression of p.T224M KCNQ1 in Chinese hamster ovary cells showed near complete loss of protein function. Our clinical and functional data enabled reclassification of p.T224M from a variant of unknown significance to pathogenic. Of the 88 carriers, 93% met criteria for beta-blocker treatment and 5/88 (5.7%) were on medications that may further prolong QTc. Carriers were provided a Clinical Laboratory Improvement Amendments confirmed report, genetic counseling, and treatment recommendations. Follow-up care was coordinated with local physicians. Conclusions: This work provides a framework by which research exome sequencing can be rapidly translated in a culturally appropriate manner to directly benefit research participants and enable population precision health.



Heart Rhythm ◽  
2007 ◽  
Vol 4 (8) ◽  
pp. 1090-1093 ◽  
Author(s):  
Komandoor Srivathsan ◽  
Apoor S. Gami ◽  
Michael J. Ackerman ◽  
Samuel J. Asirvatham


2012 ◽  
Vol 3 (5) ◽  
pp. 155-157 ◽  
Author(s):  
Michael Lieb ◽  
Timothy Orr ◽  
Christopher Gallagher ◽  
Hadi Moten ◽  
Jonathan M. Tan


Heart Rhythm ◽  
2006 ◽  
Vol 3 (7) ◽  
pp. 771-778 ◽  
Author(s):  
Richard C. Saumarez ◽  
Mariusz Pytkowski ◽  
Maciej Sterlinski ◽  
Richard N.W. Hauer ◽  
Richard Derksen ◽  
...  


2019 ◽  
pp. 01-03
Author(s):  
Josef Finsterer ◽  
Claudia Stöllberger

In a recent article, Szulik et al. reported about a 22 years old female with ventricular fibrillation, QT-prolongation, and left ventricular hypertrabeculation/noncompaction (LVHT) who died from hypoxic cerebral damage 5 days after admission [1]. We have the following comments and concerns. Patients with LVHT have a disposition for any type of cardiac arrhythmia [2,3]. This is why ventricular fibrillation not only could be due to hereditary long-QT syndrome but also due to LVHT. Ventricular fibrillation was either due to LVHT or a consequence of QT-prolongation. QT-prolongation is not unusual in LVHT and has been reported in several cases (table 1) [3-7]. LVHT has been also reported in association with long-QT-syndrome due to mutations in the KCNQ1 gene [8], in the KCNH2 gene [9], or due to an unidentified genetic defect (table 1) [10]. In a study of 105 patients with LVHT, the QT-interval increased during a mean follow up of 3.6y in 15 patients and normalized in 21 patients [11]. The increase was associated with the extension of LVHT and the presence of a neuromuscular disorder (NMD) [11].



Author(s):  
Kanae Hasegawa ◽  
Kentaro Ishida ◽  
Shinsuke Miyazaki ◽  
Seiko Ohno ◽  
Minoru Horie ◽  
...  

Mutant cardiac ryanodine receptor channels (RyR2) are “leaky,” and spontaneous Ca2+ release through these channels causes delayed afterdepolarizations that can deteriorate into ventricular fibrillation (VF). RYR2 is a causative gene of type 1 catecholaminergic polymorphic ventricular tachycardia (CPVT). Some patients carrying RYR2 mutations in CPVT exhibit QT prolongation and are initially diagnosed with long QT syndrome. However, none have been reported to cause drug-induced VF in patients with RYR2 variants. We describe the first case of an elderly woman with drug-induced QT prolongation and VF who carried a novel RYR2variant but no other mutations related to long QT syndrome.





Circulation ◽  
2002 ◽  
Vol 106 (4) ◽  
pp. 521-522 ◽  
Author(s):  
Peter Ott ◽  
Frank I. Marcus ◽  
Arthur J. Moss


Sign in / Sign up

Export Citation Format

Share Document